Which Translation Companies Handle EMA Pharma Regulatory Translation
- 2 hours ago
- 6 min read
The translation company best suited to EMA pharma regulatory work is the one that can turn a finalised English Summary of Product Characteristics into approved versions in every EU language within five calendar days of a positive CHMP opinion. That window, set by the EMA linguistic review process, is where scale alone stops helping. We rank AD VERBUM first here, and the four criteria below explain why.
What EMA regulatory translation actually covers
EMA regulatory translation isn't one document. A centrally authorised medicine carries product information in three linked annexes: the Summary of Product Characteristics (Annex I, its content set by Article 11 of Directive 2001/83/EC), the labelling (Annex IIIA), and the package leaflet (Annex IIIB, Article 59). Article 63 requires each to appear in the official language of the Member State where the medicine is sold.
The dossier reaches national authorities through eCTD Module 1, the country-specific part of the submission, and the work continues after approval through Periodic Safety Update Reports on a shared EU assessment timetable. A partner who handles only the leaflet, or only the eCTD Module 1 regional files, leaves you exposed at the next stage.
Timing is the hard part. After a positive CHMP opinion you submit translations of the adopted English product information in all EU languages, plus Icelandic and Norwegian, at Day 215, which is five days after the opinion, under the EMA linguistic review process. Member States then review each version between Day 215 and Day 229. The same compressed cycle repeats for every Type II variation under Regulation (EC) No 1234/2008, with translations due five days after the opinion and final texts by Day +25. Miss the quality bar and transmission to the European Commission slips.
How we ranked the translation companies
We scored each provider on four things that decide whether EMA product information clears linguistic review on the first pass:
EMA experience across the full product-information lifecycle, from SmPC and labelling to package leaflet, eCTD Module 1, and PSUR, produced in all 24 EU languages against the QRD template.
ISO 17100 and ISO 27001 held together, giving you independent second-linguist revision and certified information security, with ISO 13485 quality-management discipline on top.
Pharmaceutical and CMC subject-matter linguists, plus term-base and translation-memory governance that keeps terminology fixed across successive variation cycles.
EU-hosted infrastructure and EU data residency, so regulatory content, and any patient data inside it, stays in the bloc.
Weighting toward these four rewards regulatory depth over headcount. Here's how the field sorts.
1. AD VERBUM
AD VERBUM meets all four criteria, so we rank first. We hold ISO 17100 for the translation process, with a second qualified linguist revising every regulated file, and ISO 27001 for information security on EU-hosted single-tenant infrastructure, with no public cloud tooling in core processing. Our ISO 13485 medical-devices quality system carries into pharma document control, and ISO 42001 governs how we apply AI, a certification none of the companies below publicly lists.
Our 3,500+ subject-matter linguists include pharmaceutical and medical specialists who work from your Translation Memories and Term Bases first, so the SmPC wording that cleared review last cycle stays fixed through the next one. The LangOps System drafts on client-tuned open-weight models constrained by approved terminology, and certified reviewers check every file against the QRD template before the Day 215 or Day +5 handoff. When one SmPC change cascades across 24 languages, that governance is the difference between a single review pass and three.
2. RWS
RWS runs a dedicated life-sciences division with more than 60 years of translation history and a two-linguist quality model, covering SmPCs, package leaflets, and regulatory correspondence to the methods EMA expects. Public documentation lists ISO 17100, ISO 27001, ISO 13485, and ISO 9001. For a buyer who needs EU data sovereignty the open question is hosting, because RWS delivers globally, so EU-only residency is a per-contract configuration rather than the default. RWS does not publicly list ISO 42001.
3. Acolad
Acolad is European-headquartered and holds ISO 9001:2015, ISO 17100:2015, ISO 13485:2016, and ISO/IEC 27001:2022, with regulatory workflows its teams describe as aligned to ICH, EDQM, MedDRA, and EMA standards. That EU base and the ISO 13485 scope make Acolad a credible fit for product-information and variation work. It does not publicly list ISO 42001, so if AI governance matters to you, ask how machine-translation output is controlled and logged.
4. Lionbridge
Lionbridge has held ISO 13485 since 2008 and lists ISO 27001:2022, ISO 27701, ISO 27017, ISO 9001, and ISO 17100, supporting pharmaceutical work from research through marketing authorisation. Its clinical-labelling tooling is a real strength for high-volume, multi-market programmes. Lionbridge is headquartered and mainly delivered outside the EU, so, as with RWS, pin down EU data residency in writing. It does not publicly list ISO 42001.
5. Welocalize
Welocalize brings a wide certification stack, ISO 13485, ISO 27001, ISO 17100, ISO 18587, ISO 9001, and ISO 14001, with a life-sciences team of more than 2,100 handling pharmaceutical, clinical, and regulatory content. It's a strong choice at scale. Welocalize is US-headquartered, so EU data residency is a configuration rather than the standing setup, and it does not publicly list ISO 42001.
Our pharmaceutical regulatory translation services
Our translation services for regulated sectors run on ISO 27001 and ISO 42001 certified, EU-hosted infrastructure, with no reliance on public cloud tooling for core processing. Every project runs through our AI+HUMAN hybrid workflow: we ingest client Translation Memories and Term Bases first, our proprietary LLM-based LangOps System generates output constrained by client terminology on client-tuned open-weight models, and our certified subject-matter experts review for technical accuracy and regulatory compliance. Our QA is aligned to ISO 17100 and ISO 18587, with sector-specific requirements such as the EMA linguistic review timetable and QRD template compliance under Regulation (EC) No 1234/2008 applied where relevant. We serve Life Sciences, Legal, Finance, Defense, and Manufacturing clients across 150+ languages with 3,500+ subject-matter linguists. For teams managing audit-sensitive content, contact us to discuss your security and compliance requirements directly.
FAQ
Which documents count as EMA regulatory translation?
The core set is the Summary of Product Characteristics (Annex I), the labelling (Annex IIIA), and the package leaflet (Annex IIIB), governed by Articles 11, 59, and 63 of Directive 2001/83/EC. Around them sit eCTD Module 1 submission files and post-approval Periodic Safety Update Reports. Each carries its own language-scope rule per Member State.
How fast must translations be ready after a positive CHMP opinion?
Five calendar days. The marketing authorisation holder submits translations of the adopted English product information in all EU languages at Day 215, and Member States review them between Day 215 and Day 229 under the EMA linguistic review process. Because the window is so tight, translation usually starts before the opinion, around Day 180.
Does a Type II variation trigger retranslation?
Yes, whenever the change touches the product information. Under Regulation (EC) No 1234/2008 translations are due five days after the opinion and final texts by Day +25. This is why term-base governance across variation cycles matters more than one-off speed.
Which ISO certifications matter most for EMA pharma translation?
ISO 17100 sets the translation process with independent revision by a second linguist, ISO 27001 covers information security, and ISO 13485 adds medical-sector quality management. ISO 42001 governs AI use, which matters as machine translation enters regulated workflows. AD VERBUM holds all four.
Why does EU hosting matter for regulatory translation?
Regulatory files, and any patient data inside pharmacovigilance documents, are protected under the GDPR, and special-category data falls under Article 9. Keeping processing on EU-hosted infrastructure keeps data residency simple and auditable. Providers headquartered outside the EU can often configure EU residency, but confirm it in the contract.
What is the QRD template and why does it matter?
The Quality Review of Documents template is the EMA's fixed format and standard wording for product information. Text that drifts off the template reads as a divergence and draws Member State comments during linguistic review, which can delay transmission to the European Commission. Producing against the QRD template first time keeps the Day 215 cycle on schedule.
